Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
105,021,048
-
Total 13F shares
-
55,206,092
-
Share change
-
+747,907
-
Total reported value
-
$3,072,290,058
-
Put/Call ratio
-
114%
-
Price per share
-
$55.64
-
Number of holders
-
246
-
Value change
-
+$54,898,638
-
Number of buys
-
117
-
Number of sells
-
119
Institutional Holders of Sarepta Therapeutics, Inc. - Common Stock (SRPT) as of Q4 2017
As of 31 Dec 2017,
Sarepta Therapeutics, Inc. - Common Stock (SRPT) was held by
246 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
55,206,092 shares.
The largest 10 holders included
BlackRock Inc., FMR LLC, Vanguard Group Inc, STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, FRED ALGER MANAGEMENT INC, HealthCor Management, L.P., DEUTSCHE BANK AG\, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and JENNISON ASSOCIATES LLC.
This page lists
246
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.